相关实验视频

Updated: Jun 29, 2025

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

针对性基因和小分子破坏N-Ras CaaX裂变改变了其局部和瘤潜在的发生

Emily R Hildebrandt¹, Shaneela A Hussain², Michelle A Sieburg³

¹Department of Biochemistry & Molecular Biology, University of Georgia, Athens, GA, USA.

Bioorganic chemistry

|April 7, 2024

概括

研究人员开发了一种研究Ras蛋白修饰的方法,通过创建Farnesylated和uncavedRas异型. 这种方法揭示了错位化和活动减少,提供了对 CaaX 蛋白质分解影响的见解.

科学领域:

生物化学生物化学
分子生物学分子生物学
细胞生物学细胞生物学

背景情况:

包括Ras GTPases在内的 CaaX蛋白在它们的C端经历了必要的翻译后修改.
这些修饰涉及先化,aaX动图的内蛋白质裂变和碳基甲基化.
一些 CaaX 蛋白质具有不可食用的序列,防止了前化后的蛋白质分解.

研究的目的:

调查 CaaX 蛋白解对 Ras 蛋白定位和功能的特定影响.
开发一个有针对性的策略来研究 CaaX 蛋白质的修饰,而不是全球蛋白酶抑制或基因删除.

主要方法:

设计了具有不可获取序列的 Ras 异形,以保持法恩西化和未化状态.
利用体外和基于细胞的测试来评估蛋白质局部化和活性.
根据Ras CaaX序列合成并测试了基于Ras CaaX序列的新型型Rce1抑制剂.

主要成果:

观察到明显的错位化和Farnesylated和uncavedRas异型体的活性降低.
证明非水解的类Rce1抑制剂模仿Ras错位效应在可切割,但不能切割的CaaX序列上.
验证了前化和不可获取的CaaX序列的实用性,用于探测蛋白质分解影响.

结论:

一个预化且不可食用的 CaaX 序列作为一种有价值的工具来研究 CaaX 蛋白解的特定效应.
这种有针对性的策略允许检查单个 CaaX 蛋白质的特性,而不会破坏更广泛的 CaaX 蛋白质组.
这些发现突显了 CaaX 蛋白解对于 Ras 蛋白适当定位和活性的功能意义.

关键词:

在这里,我们可以看到Erk Erk Erk.蛋白酶抑制剂是一种蛋白酶抑制剂.蛋白质法纳基化是蛋白质法纳基化.拉斯蛋白 (Ras protein) 是一种蛋白质.在Rce1 CaaX蛋白酶中.

更多相关视频

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

相关概念视频

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

Small GTPases - Ras and Rho

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...